Table 3.
Method | Data set | Validation | Pearson’s ρ | σ (kcal/mol) |
---|---|---|---|---|
mCSMa | SP1 | 5-fold Positionc | 0.54 | 1.23 |
MAESTRO | SP1 | 5-fold Positionc | 0.67 | 1.12 |
mCSMa | SP1 | 5-fold Proteinc | 0.51 | 1.26 |
MAESTRO | SP1 | 5-fold Proteind | 0.63 | 1.17 |
mCSMa | SP1 351d | Blind Position | 0.67 | 1.19 |
DUETb | SP1 351d | Blind Position | 0.71 | 1.13 |
MAESTRO | SP1 351e | Blind Position | 0.71 | 1.16 |
aResults derived from Pires et al. [14], supplementary material. bResults derived from Pires et al. [15]. c5-fold cross validation on position level. All mutations of a certain mutation site are either in the test or training set. d5-fold cross validation on protein level. All mutations of a certain protein are either in the test or training set. eBlind test on a subset of the SP1 data set, provided by Pires et al. [14]. The set includes 351 mutants, whose positions are not in the remaining training set.